Thrombosis

Oral contraceptive use and hormone therapy were associated with an increased risk for stroke, according to study findings published in Stroke.

Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy, according to Richard A. Furie, MD, of Northwell Health in New York.

Aaron T. Gerds, MD, MS, spoke with Healio about the REVEAL study, results of which were presented at this year’s European Hematology Association Congress.

A recent study showed that patients with long COVID had a greater risk for abnormal blood clotting.

Individuals with long COVID may have a higher risk for abnormal blood clotting, especially those who have difficulties with basic exercise for more than 12 weeks after infection, according to a study published in Blood Advances.

Direct oral anticoagulants (DOACs) or warfarin in patients with central venous thrombosis.

In patients with cerebral venous thrombosis, direct oral anticoagulants were safer than warfarin without compromising efficacy, researchers reported at the International Stroke Conference.

In this video, Allyson Pishko, MD, MSCE, spoke with Healio about data from the ASH Annual Meeting and Exposition on COVID-19 and the safety of the vaccines in regard to the risk for deep vein thrombotic events.

In this video, Aaron T. Gerds, MD, MS, discusses critical takeaways from the REVEAL study presented at ASH Annual Meeting and Exposition.

The Advisory Committee on Immunization Practices voted 15-0 in favor of a statement indicating that mRNA COVID-19 vaccines are preferred over the Johnson & Johnson COVID-19 vaccine to prevent COVID-19 among people aged 18 years and older.